Unicycive Therapeutics, Inc. (UNCY)
USD 0.66
(-5.93%)
USD 0.66
(-5.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 675 Thousand | 951 Thousand | - | - | - | - |
| Cost of Revenue | 284 Thousand | 7000.00 | 1000.00 | - | - | - |
| Gross Profit | 391 Thousand | 944 Thousand | -1000.00 | - | - | - |
| Operating Expenses | 21.44 Million | 19 Million | 8.97 Million | 2.02 Million | 1.96 Million | 952 Thousand |
| Selling, General and Administrative Expenses | 8.54 Million | 6.56 Million | 2.89 Million | 1 Million | 1.16 Million | 608 Thousand |
| Research and Development Expenses | 12.9 Million | 12.43 Million | 6.08 Million | 1.01 Million | 795 Thousand | 344 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 21.44 Million | 19 Million | 8.97 Million | 2.02 Million | 1.96 Million | 952 Thousand |
| Operating Income | -20.77 Million | -18.05 Million | -8.97 Million | -2.02 Million | -1.96 Million | -952 Thousand |
| Interest Expense | 82 Thousand | 6000.00 | 628 Thousand | 244 Thousand | 139 Thousand | - |
| Income Tax Expense | - | 6000.00 | 615 Thousand | 244 Thousand | 139 Thousand | -952 Thousand |
| Earnings before Tax | -30.54 Million | -18.05 Million | -10.01 Million | -2.26 Million | -2.16 Million | -1.12 Million |
| Net Income | -30.54 Million | -18.06 Million | -10.63 Million | -2.5 Million | -2.3 Million | -1.12 Million |
| Earnings Per Share Basic | -1.28 | -1.20 | -0.71 | -0.16 | -0.27 | -0.14 |
| Earnings Per Share Diluted | -1.28 | -1.20 | -0.71 | -0.16 | -0.27 | -0.14 |
| Weighted Average Shares Outstanding | 24.53 Million | 15.05 Million | 14.99 Million | 15.24 Million | 8.42 Million | 7.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 24.53 Million | 15.05 Million | 14.99 Million | 15.24 Million | 8.47 Million | 7.94 Million |
| Gross Margin | 0.58 | 0.99 | - | - | - | - |
| EBIT Margin | -44.71 | -18.98 | - | - | - | - |
| Profit Margin | -45.25 | -18.99 | - | - | - | - |
| EBITDA | -30.17 Million | -18.04 Million | -8.97 Million | - | -63 Thousand | - |
| Earnings Before Tax Margin | -30.78 | -18.98 | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 675 Thousand | -271 Thousand | - | - |
| Cost of Revenue | - | 284 Thousand | 284 Thousand | 82 Thousand | 79 Thousand | 78 Thousand |
| Gross Profit | - | -284 Thousand | 391 Thousand | -353 Thousand | -79 Thousand | -78 Thousand |
| Operating Expenses | 7.4 Million | 8.92 Million | 21.16 Million | 6.23 Million | 5.93 Million | 4.32 Million |
| Selling, General and Administrative Expenses | 2.53 Million | 2.1 Million | - | 1.99 Million | 2.56 Million | 2.05 Million |
| Research and Development Expenses | 4.86 Million | 6.81 Million | - | 4.23 Million | 3.37 Million | 2.26 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 7.4 Million | 9.2 Million | 21.44 Million | 6.31 Million | 5.93 Million | 4.32 Million |
| Operating Income | -7.4 Million | -9.2 Million | -20.77 Million | -6.31 Million | -5.93 Million | -4.32 Million |
| Interest Expense | 16 Thousand | 20 Thousand | 82 Thousand | 19 Thousand | -18 Thousand | 32 Thousand |
| Income Tax Expense | 5.92 Million | 240.72 Thousand | 116.1 Thousand | -10.53 Million | -79 Thousand | 32 Thousand |
| Earnings before Tax | 9.85 Million | -20.96 Million | -30.54 Million | -7.79 Million | -4.4 Million | -3.83 Million |
| Net Income | 3.93 Million | -20.96 Million | -30.54 Million | -7.79 Million | -4.4 Million | -3.83 Million |
| Earnings Per Share Basic | 0.08 | -0.60 | - | -0.22 | -0.13 | -0.25 |
| Earnings Per Share Diluted | 0.08 | -0.60 | - | -0.22 | -0.13 | -0.25 |
| Weighted Average Shares Outstanding | 37.91 Million | 34.91 Million | 24.53 Million | 34.75 Million | 32.63 Million | 15.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.91 Million | 34.91 Million | 24.53 Million | 34.75 Million | 32.63 Million | 15.23 Million |
| Gross Margin | - | - | 0.58 | 1.30 | - | - |
| EBIT Margin | - | - | - | 22.99 | - | - |
| Profit Margin | - | - | -45.25 | 28.77 | - | - |
| EBITDA | -7.4 Million | -8.92 Million | - | -6.23 Million | -5.93 Million | -4.01 Million |
| Earnings Before Tax Margin | - | - | -30.78 | 23.30 | - | - |
KANCHI
BML
605333
300011
0188
NDA